Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POTE ankyrin domain family member J (POTEJ) is a protein coding gene in humans and a member of the ankyrin repeat domain-containing POTE protein family[3][4]. It is predicted to bind protein kinases and play a role as a structural constituent of the postsynaptic actin cytoskeleton, axonogenesis, and cell motility, with gene expression noted across diverse tissues[3][4]. Mutational data from cancer cell lines and an association with focal segmental glomerulosclerosis suggest possible disease relevance, though POTEJ is not currently established as a clinical or therapeutic target[3][4][6]. Genetic identifiers include HGNC: 37094, NCBI Gene: 653781, Ensembl: ENSG00000222038, and UniProt: P0CG39[3][4][8].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POTE ankyrin domain family member J (POTEJ).